Spatial biology at PMWC 2027

Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website

19 organizations at PMWC 2027 present work in spatial biology & tissue architecture: 9 universities, institutes and medical centers, 9 technology and service companies and 1 drug developer. Between them they bring 58 presentations to the program. Most represented: Stanford University (23 on the program), Genentech (5 on the program), Broad Institute (5 on the program). As of Nov 10, 2026.

All 296 organizations at PMWC 2027 →

Format
Top represented
Showing 1–7 of 19 organizations
OrganizationPMWC 2027 Attendance
Universities & research institutesExhibitor
Private research university; most of its speakers here are from Stanford Medicine, whose genomics and personalized medicine center exhibits.
Booth
Exhibiting at Booth A402
PMWC Luminary Award honoree
3 PMWC Pioneer Award honorees
Panel
Wed Jan 27
9:20am
Part of Track 2: Multimodal AI in Diagnostics
Fireside Chat
with Microsoft
Panel
Wed Jan 27
9:45am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Off-the-Shelf Cell Therapies: NK, iPSC, and Allogeneic T Cells, What Wins?
with Allogene Therapeutics, Nkarta, MD Anderson Cancer Center
Panel
Wed Jan 27
9:45am
Part of Track 2: Multimodal AI in Diagnostics
Beyond the Glass Slide: What Computational Pathology Sees That Humans Cannot
with Emory University, University of Pittsburgh, PathAI
Panel
Wed Jan 27
11:00am
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Proteomics: From Cell States to Therapeutic Targets
with Genentech
Panel
Wed Jan 27
1:00pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
Treating Disease at the Earliest Stage
with Harvard University, Dana-Farber Cancer Institute
Panel
Wed Jan 27
2:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Why Cell Therapies Fail in Solid Tumors and What Actually Works
with Rutgers Cancer Institute, USC, Weill Cornell Medicine +1 more
Panel
Wed Jan 27
2:30pm
Part of Track 5: Spatial Biology and Tissue Architecture
AI for Spatial Biology: Foundation Models and Digital Pathology
with MIT
Panel
Wed Jan 27
4:15pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
SESSION 5B - AI Across Multimodal Signals
with Harvard University, Dana-Farber Cancer Institute, UCSF +1 more
Track
Thu Jan 28
All day
Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Track chair
Talk
Thu Jan 28
11:00am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Cell-free RNA for treatment response and resistance.
Panel
Thu Jan 28
11:15am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Advanced Cancer and Recurrence: Monitoring Response, Detecting Resistance, and Knowing When to Switch
with Johns Hopkins University, AstraZeneca, Quest Diagnostics +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 4: Integration & Implementation of Precision Medicine
CDS That Clinicians Will Use
with University of Pennsylvania, UCSF, VA Palo Alto Health Care System +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Turning Biomarkers on Their Head: What We Can Measure Before We Can Predict
with UCSF, Genentech, Yale University +1 more
Panel
Thu Jan 28
2:15pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
When Tissue, Liquid, and Imaging Disagree: Which Result Should Guide Treatment?
with Adaptive Biotechnologies, Mount Sinai, Agilent
Panel
Thu Jan 28
3:30pm
Part of Track 2: Clinical AI: Deployment, Decision Support and RWE
AI Safety, Governance, and Evaluation
with Coalition for Health AI, UC Berkeley, UCSF +2 more
Panel
Thu Jan 28
3:30pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
MRD as a Surrogate Endpoint for Accelerated Drug Approval: Successes and Challenges
with University of Miami, Virginia Tech, Amgen +4 more
Panel
Thu Jan 28
3:30pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
The Microbial Roots of Autoimmunity: Chronic Infection and Dysbiosis
with NYU Langone Health, Gilead Sciences
Panel
Fri Jan 29
9:15am
Part of Track 3: Blood-Based Diagnostics Beyond Cancer
Transplant & Organ Health Diagnostics: From Biopsy to Noninvasive Monitoring
with Cornell University, KU Leuven, AP-HP +1 more
Panel
Fri Jan 29
9:30am
Part of Track 1: Programmable Genetic Medicines
Programming Protein Fate: Molecular Glues, Degraders, and Induced Proximity
with Amgen, Nurix Therapeutics
Panel
Fri Jan 29
11:00am
Part of Track 3: Blood-Based Diagnostics Beyond Cancer
Diagnosing the Undiagnosed: Blood-Based Omics and Host Response in Infection
with UCSF, CDC, Karius
Panel
Fri Jan 29
1:00pm
Part of Track 5: Precision Neurology & Neurodegenerative Disease
Neurodegeneration Beyond AD: Parkinson’s, ALS, FTD
with MIT, University of Pennsylvania, Mass General Brigham +1 more
Panel
Fri Jan 29
2:00pm
Part of Track 1: Programmable Genetic Medicines
In Vivo Delivery and Vector Engineering
with UC Berkeley, Lyora Therapeutics, Scribe Therapeutics
Panel
Fri Jan 29
2:15pm
Part of Track 4: Precision Aging, Prevention & Healthspan
Wearables & Digital Biomarkers at Scale
with Google, Amsterdam UMC, Apple
Also
Presenting at the meeting, beyond the sessions above
Genentech
South San Francisco, CA
Large pharma
Biotechnology company and member of the Roche Group, with marketed medicines in oncology, immunology, neuroscience and ophthalmology.
PMWC Pioneer Award honoree
Panel
Wed Jan 27
9:30am
Part of Track 5: Spatial Biology and Tissue Architecture
The Next Map of Biology: From the Human Genome to the Human Cell Atlas in the AI Era
with Broad Institute, Massachusetts General Hospital
Panel
Wed Jan 27
11:00am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
AI in Cell Therapy: Research to Commercialization
with Aspen Neuroscience, Benchling, Kite Pharma
Panel
Wed Jan 27
11:00am
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Proteomics: From Cell States to Therapeutic Targets
with Stanford University
Panel
Thu Jan 28
1:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Turning Biomarkers on Their Head: What We Can Measure Before We Can Predict
with UCSF, Stanford University, Yale University +1 more
Panel
Thu Jan 28
4:30pm
Part of Track 2: Clinical AI: Deployment, Decision Support and RWE
Pharma Scaling — From Pilots to Enterprise AI
with Takeda, Pfizer
Broad Institute
Cambridge, MA
Universities & research institutes
Biomedical research institute of MIT and Harvard working in genomics, cancer, psychiatric disease and computational biology.
PMWC Pioneer Award honoree
Panel
Wed Jan 27
9:30am
Part of Track 5: Spatial Biology and Tissue Architecture
The Next Map of Biology: From the Human Genome to the Human Cell Atlas in the AI Era
with Genentech, Massachusetts General Hospital
Panel
Wed Jan 27
3:30pm
Part of Track 5: Spatial Biology and Tissue Architecture
Scaling Spatial Biology from Discovery to Clinical Translation
with PathAI, Brigham and Women's Hospital, Castle Biosciences +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
From Blood to Drug: Liquid Biopsy for Therapy Selection
with Fred Hutch Cancer Center, Medical College of Wisconsin, Memorial Sloan Kettering Cancer Center
Panel
Fri Jan 29
11:00am
Part of Track 2: AI in Drug Discovery & Computational Biology
Data Is the Moat: Who Wins the AI Drug Race?
with Chai Discovery, Noetik, Eli Lilly +3 more
Also
Presenting at the meeting, beyond the sessions above
Emory University
Atlanta, GA
Universities & research institutes
Private research university with a medical school, the Winship Cancer Institute and joint biomedical engineering with Georgia Tech.
Panel
Wed Jan 27
9:45am
Part of Track 2: Multimodal AI in Diagnostics
Beyond the Glass Slide: What Computational Pathology Sees That Humans Cannot
with Stanford University, University of Pittsburgh, PathAI
Panel
Wed Jan 27
1:00pm
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Pathology from Discovery to Clinical Biomarker
with University Hospital Schleswig-Holstein, Bruker Spatial Biology
Panel
Fri Jan 29
4:15pm
Part of Track 5: Precision Neurology & Neurodegenerative Disease
Beyond Pharmacology: Gamma Stimulation, Brain Circuits, and the Future of Neurotherapy
with MIT
Universities & research institutes
Cancer research and treatment center, with research in cancer genomics, immunotherapy and liquid biopsy.
Panel
Wed Jan 27
10:00am
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Biology in Practice: From Tissue to Decisions
with University of Cambridge
Panel
Thu Jan 28
11:15am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Advanced Cancer and Recurrence: Monitoring Response, Detecting Resistance, and Knowing When to Switch
with Stanford University, Johns Hopkins University, AstraZeneca +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
From Blood to Drug: Liquid Biopsy for Therapy Selection
with Medical College of Wisconsin, Memorial Sloan Kettering Cancer Center, Broad Institute
MIT
Cambridge, MA
Universities & research institutes
The Massachusetts Institute of Technology, a research university whose institutes include the Picower Institute for neuroscience.
PMWC Pioneer Award honoree
Panel
Wed Jan 27
2:30pm
Part of Track 5: Spatial Biology and Tissue Architecture
AI for Spatial Biology: Foundation Models and Digital Pathology
with Stanford University
Panel
Fri Jan 29
1:00pm
Part of Track 5: Precision Neurology & Neurodegenerative Disease
Neurodegeneration Beyond AD: Parkinson’s, ALS, FTD
with Stanford University, University of Pennsylvania, Mass General Brigham +1 more
Panel
Fri Jan 29
4:15pm
Part of Track 5: Precision Neurology & Neurodegenerative Disease
Beyond Pharmacology: Gamma Stimulation, Brain Circuits, and the Future of Neurotherapy
with Emory University
Hospitals, health systems & payers
Harvard teaching hospital and member of Mass General Brigham, with a cancer center and large research programs.
Panel
Wed Jan 27
9:30am
Part of Track 5: Spatial Biology and Tissue Architecture
The Next Map of Biology: From the Human Genome to the Human Cell Atlas in the AI Era
with Broad Institute, Genentech
Panel
Wed Jan 27
3:30pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
SESSION 5A - Increasing the Signal: Can We Make Liquid Biopsy More Sensitive?
with Harvard University, Johns Hopkins University, Northwestern University +2 more
Panel
Thu Jan 28
11:00am
Part of Track 1: Immunotherapies & Targeted Therapies
Biomarkers That Matter: Selecting Patients for IO and Targeted Therapy
with Yale University, Olink, Parker Institute for Cancer Immunotherapy +3 more
Panel
Thu Jan 28
11:15am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Advanced Cancer and Recurrence: Monitoring Response, Detecting Resistance, and Knowing When to Switch
with Stanford University, Johns Hopkins University, AstraZeneca +2 more

Explore the full PMWC 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Santa Clara. Leave your work email and we’ll be in touch.

Privacy

Download the full PMWC 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in spatial biology & tissue architecture

Tell us what you sell and we’ll find the people at organizations working on spatial biology & tissue architecture most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse PMWC 2027 by

Exhibit hall

Not affiliated with or endorsed by PMWC or its organizers. Submit a correction